A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Oral Sildenafil Citrate in Treatment-Naive Children With Pulmonary Arterial Hypertension

Arterial Hypertension ◽

Sildenafil Citrate ◽

Double Blind ◽

Double Blind Placebo ◽

Treatment Naïve ◽

Dose Ranging ◽

Faculty Opinions recommendation of A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717967956.793467610 ◽

2012 ◽

Author(s):

Robin Steinhorn

Keyword(s):

Arterial Hypertension ◽

Sildenafil Citrate ◽

Double Blind ◽

Double Blind Placebo ◽

Treatment Naïve ◽

Dose Ranging ◽

Efficacy and safety of sildenafil citrate in Pulmonary Arterial Hypertension (PAH): Results of a multinational, randomized, double-blind, placebo-controlled trial

American Journal of Hypertension ◽

10.1016/j.amjhyper.2005.03.260 ◽

2005 ◽

Vol 18 (5) ◽

pp. A93-A93

Author(s):

L RUBIN ◽

G BURGESS ◽

T PARPIA ◽

D BADESCH

Keyword(s):

Arterial Hypertension ◽

Controlled Trial ◽

Sildenafil Citrate ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Selonsertib in adults with pulmonary arterial hypertension (ARROW): a randomised, double-blind, placebo-controlled, phase 2 trial

The Lancet Respiratory Medicine ◽

10.1016/s2213-2600(21)00032-1 ◽

2021 ◽

Author(s):

Stephan Rosenkranz ◽

Jeremy Feldman ◽

Vallerie V McLaughlin ◽

Franz Rischard ◽

Tobias J Lange ◽

...

Keyword(s):

Arterial Hypertension ◽

Phase 2 ◽

Double Blind ◽

Double Blind Placebo ◽

Phase 2 Trial ◽

Neprilysin inhibition for pulmonary arterial hypertension: a randomized, double‐blind, placebo‐controlled, proof‐of‐concept trial

British Journal of Pharmacology ◽

10.1111/bph.14621 ◽

2019 ◽

Vol 176 (9) ◽

pp. 1251-1267 ◽

Cited By ~ 7

Author(s):

Adrian J. Hobbs ◽

Amie J. Moyes ◽

Reshma S. Baliga ◽

Dipa Ghedia ◽

Rachel Ochiel ◽

...

Keyword(s):

Arterial Hypertension ◽

Proof Of Concept ◽

Double Blind ◽

Double Blind Placebo ◽

Pulmonary Arterial ◽

Neprilysin Inhibition

Double-Blind, Placebo-Controlled Clinical Trial With a Rho-Kinase Inhibitor in Pulmonary Arterial Hypertension

Circulation Journal ◽

10.1253/circj.cj-13-0443 ◽

2013 ◽

Vol 77 (10) ◽

pp. 2619-2625 ◽

Cited By ~ 96

Author(s):

Yoshihiro Fukumoto ◽

Norikazu Yamada ◽

Hiromi Matsubara ◽

Minori Mizoguchi ◽

Kazuaki Uchino ◽

...

Keyword(s):

Clinical Trial ◽

Arterial Hypertension ◽

Kinase Inhibitor ◽

Rho Kinase ◽

Controlled Clinical Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Rho Kinase Inhibitor ◽

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ILOPROST INHALATION AS ADD-ON THERAPY TO BOSENTAN IN PULMONARY ARTERIAL HYPERTENSION (PAH)

CHEST Journal ◽

10.1378/chest.128.4_meetingabstracts.160s ◽

2005 ◽

Vol 128 (4) ◽

pp. 160S ◽

Cited By ~ 4

Author(s):

Vallerie V. McLaughlin ◽

Ronald Oudiz ◽

Adaani Frost ◽

Victor Tapson ◽

Srinivas Murali ◽

...

Keyword(s):

Arterial Hypertension ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension. A Double-Blind Placebo-controlled Clinical Trial

American Journal of Respiratory and Critical Care Medicine ◽

10.1164/rccm.201908-1640oc ◽

2020 ◽

Vol 201 (6) ◽

pp. 707-717 ◽

Cited By ~ 15

Author(s):

R. James White ◽

Carlos Jerjes-Sanchez ◽

Gisela Martina Bohns Meyer ◽

Tomas Pulido ◽

Pablo Sepulveda ◽

...

Keyword(s):

Clinical Trial ◽

Combination Therapy ◽

Arterial Hypertension ◽

Controlled Clinical Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Faculty Opinions recommendation of Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1115300.571310 ◽

2008 ◽

Author(s):

John Augoustides

Keyword(s):

Arterial Hypertension ◽

Double Blind ◽

Double Blind Placebo ◽

Riociguat for the Treatment of Pulmonary Arterial Hypertension: A Randomized, Double-Blind, Placebo-Controlled Study (PATENT-1)

CHEST Journal ◽

10.1378/chest.1462799 ◽

2012 ◽

Vol 142 (4) ◽

pp. 1027A ◽

Cited By ~ 17

Author(s):

Hossein Ghofrani ◽

Nazzareno Galie ◽

Friedrich Grimminger ◽

Marc Humbert ◽

Anne Keogh ◽

...

Keyword(s):

Arterial Hypertension ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

PULSAR: A phase 2, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of sotatercept (ACE-011) when added to standard of care (SOC) for treatment of pulmonary arterial hypertension (PAH)

10.1183/13993003.congress-2019.pa4750 ◽

2019 ◽

Author(s):

David Badesch ◽

Simon Gibbs ◽

Mardi Gomberg-Maitland ◽

Marc Humbert ◽

Vallerie Mclaughlin ◽

...

Keyword(s):

Arterial Hypertension ◽

Standard Of Care ◽

Controlled Study ◽

Phase 2 ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽